IT1283911B1 - Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo - Google Patents

Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo

Info

Publication number
IT1283911B1
IT1283911B1 IT96RM000075A ITRM960075A IT1283911B1 IT 1283911 B1 IT1283911 B1 IT 1283911B1 IT 96RM000075 A IT96RM000075 A IT 96RM000075A IT RM960075 A ITRM960075 A IT RM960075A IT 1283911 B1 IT1283911 B1 IT 1283911B1
Authority
IT
Italy
Prior art keywords
pct
ophthalmic
date aug
sec
concentrations
Prior art date
Application number
IT96RM000075A
Other languages
English (en)
Inventor
Marco Fabrizio Saettone
Susi Burgalassi
Boris Giannaccini
Enrico Boldrini
Pietro Bianchini
Giulio Luciani
Original Assignee
Farmigea Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmigea Spa filed Critical Farmigea Spa
Publication of ITRM960075A0 publication Critical patent/ITRM960075A0/it
Priority to IT96RM000075A priority Critical patent/IT1283911B1/it
Priority to DE69706410T priority patent/DE69706410T2/de
Priority to DK97902574T priority patent/DK0892636T3/da
Priority to AU16178/97A priority patent/AU1617897A/en
Priority to SI9730223T priority patent/SI0892636T1/xx
Priority to JP52835697A priority patent/JP3872515B2/ja
Priority to CA002245617A priority patent/CA2245617C/en
Priority to KR10-1998-0705973A priority patent/KR100430260B1/ko
Priority to AT97902574T priority patent/ATE204745T1/de
Priority to PCT/IT1997/000026 priority patent/WO1997028787A1/en
Priority to PT97902574T priority patent/PT892636E/pt
Priority to ES97902574T priority patent/ES2164327T3/es
Priority to US09/117,728 priority patent/US6056950A/en
Priority to EP97902574A priority patent/EP0892636B1/en
Priority to EA199800689A priority patent/EA001067B1/ru
Publication of ITRM960075A1 publication Critical patent/ITRM960075A1/it
Application granted granted Critical
Publication of IT1283911B1 publication Critical patent/IT1283911B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
IT96RM000075A 1996-02-05 1996-02-05 Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo IT1283911B1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT96RM000075A IT1283911B1 (it) 1996-02-05 1996-02-05 Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
AT97902574T ATE204745T1 (de) 1996-02-05 1997-02-04 Mit tamarindensamenpolysacchariden verdickte opthalmische lösungen
PT97902574T PT892636E (pt) 1996-02-05 1997-02-04 Solucoesoftalmicas tornadas viscosas com polissacarido de semente de tamarindo
AU16178/97A AU1617897A (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
SI9730223T SI0892636T1 (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
JP52835697A JP3872515B2 (ja) 1996-02-05 1997-02-04 タマリンド種子多糖で粘稠化された点眼液
CA002245617A CA2245617C (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
KR10-1998-0705973A KR100430260B1 (ko) 1996-02-05 1997-02-04 타마린드씨폴리사카라이드로점성을제공한안약
DE69706410T DE69706410T2 (de) 1996-02-05 1997-02-04 Mit tamarindensamenpolysacchariden verdickte opthalmische lösungen
PCT/IT1997/000026 WO1997028787A1 (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
DK97902574T DK0892636T3 (da) 1996-02-05 1997-02-04 Med tamarindfrøpolysaccharider fortykkede ophthalmiske opløsninger
ES97902574T ES2164327T3 (es) 1996-02-05 1997-02-04 Soluciones oftalmicas hechas viscosas mediante polisacarido procedente de semillas de tamarindo.
US09/117,728 US6056950A (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
EP97902574A EP0892636B1 (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
EA199800689A EA001067B1 (ru) 1996-02-05 1997-02-04 Офтальмологические растворы, загущенные с помощью полисахаридов семян тамаринда

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000075A IT1283911B1 (it) 1996-02-05 1996-02-05 Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo

Publications (3)

Publication Number Publication Date
ITRM960075A0 ITRM960075A0 (it) 1996-02-05
ITRM960075A1 ITRM960075A1 (it) 1997-08-05
IT1283911B1 true IT1283911B1 (it) 1998-05-07

Family

ID=11403863

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96RM000075A IT1283911B1 (it) 1996-02-05 1996-02-05 Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo

Country Status (14)

Country Link
US (1) US6056950A (it)
EP (1) EP0892636B1 (it)
JP (1) JP3872515B2 (it)
KR (1) KR100430260B1 (it)
AT (1) ATE204745T1 (it)
AU (1) AU1617897A (it)
CA (1) CA2245617C (it)
DE (1) DE69706410T2 (it)
DK (1) DK0892636T3 (it)
EA (1) EA001067B1 (it)
ES (1) ES2164327T3 (it)
IT (1) IT1283911B1 (it)
PT (1) PT892636E (it)
WO (1) WO1997028787A1 (it)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291892B1 (it) * 1997-04-24 1999-01-21 Alessandro Lambiase Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella
CN1762381B (zh) 1997-07-29 2012-07-11 爱尔康实验室公司 含半乳甘露聚糖聚合物和硼酸盐的眼用组合物
IT1305294B1 (it) 1999-01-29 2001-05-04 Alessandro Lambiase Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari.
EP1156809B1 (en) 1999-03-01 2005-12-07 Vista Scientific LLC Mucin containing ophthalmic preparations
AU2002232437A1 (en) 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic lubricating solution adapted for use in lasik surgery
US6878694B2 (en) 2000-12-20 2005-04-12 Alcon, Inc. Ophthalmic irrigating solution adapted for use in lasik surgery
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
DK1363600T3 (da) * 2001-02-15 2009-01-26 Access Pharma Inc Flydende formuleringer til forebyggelse og behandling af mucosale sygdomme og lidelser
US6465506B2 (en) * 2001-02-22 2002-10-15 Ophthalmic Research Associates, Inc. Instillation techniques for ophthalmic agents to enhance treatment effect
CA2447383A1 (en) 2001-06-29 2003-01-09 Biovitrum Ab Process for bulk autoclaving
CA2701551A1 (en) * 2001-08-10 2003-02-20 Masahiro Inohara Polysaccharide-containing compositions and use thereof
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein
US20040214754A1 (en) * 2001-10-03 2004-10-28 Ellis Edward J. Ophthalmic preparation containing glycomacropeptide
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
EP2130541A3 (en) 2002-07-29 2013-12-18 Rigel Pharmaceuticals, Inc. Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
ES2365223T3 (es) 2003-08-07 2011-09-26 Rigel Pharmaceuticals, Inc. Compuestos 2,4-pirimidindiamínicos y usos como agentes antiproliferativos.
EP2113246B1 (en) * 2003-08-07 2016-06-22 Allergan, Inc. Compositions for delivery of therapeutics into the eyes and methods for making and using the same
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
EP1683528A4 (en) * 2003-11-10 2011-07-27 Toray Industries POLYSACCHARIDE-CONTAINING COMPOSITION AND OPHTHALMIC SOLUTION FOR STABILIZING THE TISSUE FILM
US20050210732A1 (en) * 2004-03-26 2005-09-29 Guerin John W Crank bait tail
JP4395016B2 (ja) * 2004-06-29 2010-01-06 日清オイリオグループ株式会社 ゲル状吸水用組成物
EP1861069B2 (en) † 2005-02-09 2013-07-03 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
PT1698630E (pt) 2005-03-03 2014-09-15 Alfa Wassermann Spa Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
ITBO20050388A1 (it) * 2005-06-06 2006-12-07 Alfa Wassermann Spa Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
ITRM20050447A1 (it) * 2005-08-19 2007-02-20 Anabasis S R L Uso del nerve growth factor in collirio nella terapia di patologie del sistema nervoso centrale, quali la malattia di alzheimer e il morbo di parkinson.
WO2007098507A2 (en) 2006-02-24 2007-08-30 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
JP5134778B2 (ja) * 2006-03-10 2013-01-30 日清オイリオグループ株式会社 ゲル組成物及び該ゲル組成物を使用したパック化粧料
EP2420505A1 (en) 2006-11-21 2012-02-22 Rigel Pharmaceuticals, Inc. Prodrug salts of 2, 4- pyrimidinediamine compounds and their uses
ITRM20070510A1 (it) * 2007-10-02 2009-04-03 Rmfa Trading S A Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
GB0719969D0 (en) 2007-10-12 2007-11-21 Cambridge Entpr Ltd Substance monitoring and control in human or animal bodies
US20110015158A1 (en) 2007-12-11 2011-01-20 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
ES2624622T3 (es) 2008-12-30 2017-07-17 Rigel Pharmaceuticals, Inc. Inhibidores de pirimidindiamina cinasa
PL2389372T3 (pl) 2009-01-23 2016-02-29 Rigel Pharmaceuticals Inc Kompozycje i sposoby hamowania szlaku JAK
CN104523661A (zh) 2009-02-06 2015-04-22 南加利福尼亚大学 含有单萜的治疗组合物
AU2010281404A1 (en) 2009-07-28 2012-02-09 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
IT1396607B1 (it) * 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
US8507734B2 (en) 2010-03-03 2013-08-13 Neonc Technologies Inc. Pharmaceutical compositions comprising monoterpenes
PL2563771T3 (pl) 2010-04-24 2016-06-30 Viamet Pharmaceuticals Nc Inc Związki inhibitora metaloenzymu
KR101790618B1 (ko) 2010-05-24 2017-10-26 인데나 에스.피.에이 염증 질환의 치료에서의 사용을 위한 타마린드 씨 다당류
MX341220B (es) * 2010-05-24 2016-08-10 Indena Spa Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas.
JP5620168B2 (ja) * 2010-06-30 2014-11-05 Ｄｓｐ五協フード＆ケミカル株式会社 キシログルカン−カチオン複合体及びそれを含有する安定化組成物
EA023654B1 (ru) * 2010-07-12 2016-06-30 Замбон Спа Полимерный полисахарид из семян тамариндового дерева для применения в лечении сухого кашля
CN103201280B (zh) 2010-07-28 2016-08-10 里格尔药品股份有限公司 抑制jak途径的组合物和方法
EP3173080B1 (en) 2010-08-27 2019-12-11 Neonc Technologies Inc. Pharmaceutical compositions comprising derivatives of perillyl alcohol
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
EP2632903A4 (en) 2010-10-28 2014-11-26 Viamet Pharmaceuticals Inc METALLOENZYMHEMMERVERBINDUNGEN
EA024197B1 (ru) 2010-11-13 2016-08-31 Иннокрин Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
BR112013015107B1 (pt) 2010-12-17 2022-03-22 Neonc Technologies Inc. Composição farmacêutica, uso de um álcool isoperílico ou um carbamato de álcool isoper ílico e processo para produzir um carbamato de álcool isoperílico
CA2828360A1 (en) 2011-02-25 2012-08-30 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Chrysophaentin analogs that inhibit ftsz protein
ITMI20110583A1 (it) 2011-04-08 2012-10-09 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di pacap (pituitary adenylate cyclase activating polypeptide) al fine di ripristinare la normale funzione visiva nel glaucoma in fase precoce
RU2463022C1 (ru) * 2011-04-19 2012-10-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения больных с синдромом "сухого глаза"
CN103608028A (zh) 2011-04-28 2014-02-26 南加利福尼亚大学 人类髓源抑制性细胞癌症标记
US8809378B2 (en) 2011-06-19 2014-08-19 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
CA2839691A1 (en) 2011-06-19 2012-12-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
US8883797B2 (en) 2011-06-23 2014-11-11 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
EP2741754B1 (en) * 2011-08-12 2015-05-27 Zambon S.p.A. Use of a polysaccharide polymer from the seeds of the tamarind tree in protecting against tobacco-associated damages
RU2598721C2 (ru) * 2011-09-07 2016-09-27 Сэндзю Фармасьютикал Ко., Лтд. Способ подавления снижения вязкости жидкого водного агента
WO2013046059A2 (en) * 2011-09-27 2013-04-04 Sykora Robert C Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose
EP2788343B1 (en) 2011-12-11 2018-02-28 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
IN2014DN06792A (it) 2012-01-20 2015-05-22 Viamet Pharmaceuticals Inc
NZ629898A (en) 2012-03-23 2016-04-29 Oxigene Inc Compositions and methods for inhibition of cathepsins
WO2013173506A2 (en) 2012-05-16 2013-11-21 Rigel Pharmaceuticals, Inc. Method of treating muscular degradation
US20160166701A1 (en) * 2013-07-05 2016-06-16 Therakine Biodelivery Gmbh Delivery composition for topical applications and injections and ophthalmic formulations, methods for manufacturing thereof, and methods for delivery of a drug-delivery composition
EP2883931A1 (en) * 2013-12-12 2015-06-17 Omya International AG Improved gel stability
CA2945631C (en) 2014-04-15 2023-04-11 Novintethical Pharma Sa Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
JP6674957B2 (ja) 2015-02-12 2020-04-01 ネオンク テクノロジーズ インク． ペリリルアルコール誘導体を含む医薬組成物
ES2705692T3 (es) 2015-06-11 2019-03-26 Novintethical Pharma Sa Composiciones nasales tópicas que contienen xiloglucanos para usar como descongestionantes
TW201707719A (zh) * 2015-07-13 2017-03-01 國立大學法人東北大學 視神經保護用組成物
DK3331879T3 (da) 2015-08-04 2020-08-10 Rigel Pharmaceuticals Inc Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne
PL3331497T3 (pl) 2015-08-07 2021-12-13 Council Of Scientific & Industrial Research Preparat nawilżający pochodnej karbamoiloetylowej katiry i sposób jego wytwarzania
MX2018008105A (es) 2015-12-30 2018-11-12 Vps 3 Inc Compuestos inhibidores de metaloenzima.
ES2940911T3 (es) 2016-06-27 2023-05-12 Rigel Pharmaceuticals Inc Compuestos de 2,4-diamino-pirimidina y su uso como inhibidores de IRAK4
WO2018081294A1 (en) 2016-10-26 2018-05-03 Rigel Pharmaceuticals, Inc. Pyrazole amide compounds as irak inhibitors
EP3532470B1 (en) 2016-10-26 2022-12-07 Rigel Pharmaceuticals, Inc. Oxazole derivatives for use as irak inhibitors and method for their preparation
WO2018102412A1 (en) 2016-11-30 2018-06-07 Neonc Technologies, Inc. A perillyl alcohol-3 bromopyruvate conjugate and methods of treating cancer
WO2018125799A2 (en) 2016-12-29 2018-07-05 Viamet Pharmaceuticals (Bermuda), Ltd. Metalloenzyme inhibitor compounds
FI3562487T3 (fi) 2016-12-29 2023-12-14 Ji Xing Pharmaceuticals Hong Kong Ltd Metalloentsyymi-inhibiittoriyhdisteitä
US10590121B2 (en) 2017-06-29 2020-03-17 Rigel Pharmaceuticals, Inc. Kinase inhibitors and methods for making and using
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
US20210292410A1 (en) 2017-12-07 2021-09-23 Morphosys Ag Treatment paradigm for an anti-cd19 antibody and venetoclax combination treatment
WO2019157195A1 (en) 2018-02-08 2019-08-15 Neonc Technologies, Inc Methods of permeabilizing the blood brain barrier
HUE063896T2 (hu) 2018-05-03 2024-02-28 Rigel Pharmaceuticals Inc RIP1 inhibitorvegyületek, valamint ezek elõállítása és alkalmazása
ES2947446T3 (es) 2018-05-03 2023-08-09 Rigel Pharmaceuticals Inc Compuestos inhibidores de RIP1 y métodos para fabricar y usar los mismos
US20220000880A1 (en) 2018-11-01 2022-01-06 Rigel Pharmaceuticals, Inc. Method and composition embodiments for treating acute myeloid leukemia
US20200377518A1 (en) 2019-05-29 2020-12-03 Rigel Pharmaceuticals, Inc. Method of preventing and treating thrombosis
WO2021026451A1 (en) 2019-08-08 2021-02-11 Rigel Pharmaceuticals, Inc. Compounds and method for treating cytokine release syndrome
CA3147444A1 (en) 2019-08-14 2021-02-18 Rigel Pharmaceuticals, Inc. Method of blocking or ameliorating cytokine release syndrome
MX2022002292A (es) 2019-08-30 2022-06-02 Rigel Pharmaceuticals Inc Compuestos de pirazol, formulaciones de los mismos y un metodo para usar los compuestos y/o formulaciones.
EP4025568A1 (en) 2019-09-06 2022-07-13 Rigel Pharmaceuticals, Inc. Rip1 inhibitory compounds and methods for making and using the same
CR20220075A (es) 2019-09-06 2022-07-14 Rigel Pharmaceuticals Inc Compuestos inhibidores de rip1 y métodos para prepararlos y usarlos
KR20220079919A (ko) 2019-11-07 2022-06-14 리겔 파마슈티칼스, 인크. 헤테로시클릭 rip1 억제 화합물
US20220288047A1 (en) 2021-03-03 2022-09-15 Rigel Pharmaceuticals, Inc. Method for treating a disease or condition using a pyrazole compound or formulation thereof
TW202300490A (zh) 2021-03-11 2023-01-01 美商雷傑製藥公司 雜環rip1激酶抑制劑
US20230303555A1 (en) 2022-03-23 2023-09-28 Rigel Pharmaceuticals, Inc. Pyrimid-2-yl-pyrazole compounds as irak inhibitors
WO2023192479A1 (en) 2022-03-31 2023-10-05 Rigel Pharmaceuticals, Inc. Tricyclic irak inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
JPH0748278A (ja) * 1992-06-10 1995-02-21 Taiho Yakuhin Kogyo Kk 鼻腔用粉末製剤

Also Published As

Publication number Publication date
EA199800689A1 (ru) 1999-02-25
EA001067B1 (ru) 2000-10-30
CA2245617A1 (en) 1997-08-14
DE69706410D1 (de) 2001-10-04
JP3872515B2 (ja) 2007-01-24
KR19990082244A (ko) 1999-11-25
ITRM960075A0 (it) 1996-02-05
EP0892636A1 (en) 1999-01-27
KR100430260B1 (ko) 2004-07-30
WO1997028787A1 (en) 1997-08-14
DE69706410T2 (de) 2002-06-06
ITRM960075A1 (it) 1997-08-05
ES2164327T3 (es) 2002-02-16
ATE204745T1 (de) 2001-09-15
PT892636E (pt) 2002-02-28
DK0892636T3 (da) 2001-12-17
CA2245617C (en) 2005-07-12
AU1617897A (en) 1997-08-28
EP0892636B1 (en) 2001-08-29
JP2000504685A (ja) 2000-04-18
US6056950A (en) 2000-05-02

Similar Documents

Publication Publication Date Title
IT1283911B1 (it) Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
AU1464995A (en) Liquid ophthalmic sustained release delivery system
DE69803940T2 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
DE69616347D1 (de) O-Carboxymethylchitosan enthaltende Mittel und ihre Verwendung in Ophthalmika
ATE220296T1 (de) Konfekt basierend auf hydrokolloid
ATE233083T1 (de) Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen
MX9708043A (es) Liberacion controlada de farmacos mioticos y midriaticos en la camara anterior.
ATE143257T1 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
DE602008005173D1 (de) Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure
BG104535A (en) Fluidized polymer suspensions of cationic polysaccharides in polyols and use thereof in preparing personal care compositions
MX9701609A (es) Composicion espesada por un alquileter de polisacarido.
Raimondi et al. A new viscosity enhancer for ophthalmic preparations devoid of toxicity for human conjunctival cells
DK0804152T3 (da) Lactulose-pastiller
KR960037046A (ko) 도파민 수용기 자극제를 포함하는 근시 및 녹내장 치료용 안과 제형
BRPI0502198A (pt) hidrogel fluido de goma guar purificada e desproteinada como agente viscoelástico aplicado na viscossuplementação de articulações com osteoartrite

Legal Events

Date Code Title Description
0001 Granted